Delivery Order SPE2DX15D3015-SPE2DX24F0FA2

Award Date 2/7/24
Potential Completion Date 2/8/24
Potential Value $2.8K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler, a specialty pharmaceutical product. The $2,099.79 contract has a completion date of February 14, 2024 and is not associated with any set-aside designations. Amerisourcebergen Drug Corp serves as the prime contractor for this award, which is part of the company's...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 mcg inhalers. The $16,859.04 contract has a completion date of February 22, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and serves as the primary supplier of pharmaceuticals and medical supplies to DLA Troop Support Medical facilities...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract (SPE2DX15D2101|SPE2DX24F50ZS) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 115-21 mcg inhalers. The $7,583.58 delivery order has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Advair HFA 115-21 MCG inhalers. The $12,577.37 contract has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This award is associated with a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $4,160.20 award is for the supply of Advair HFA 230-21 MCG Inhaler 12GM, a pharmaceutical product. The contract has a completion date of February 20, 2024 and was awarded on February 16, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Advair HFA 230-21 MCG Inhaler 12GM medication. The $3,975.72 contract has a performance period through March 26, 2024 and does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is placed against a $999,999,999.00 indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Advair HFA 230-21 mcg inhalers. The contract has a potential value of $1,356.29 and a performance period ending on January 31, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this award, which is not designated as a set-aside contract. This delivery order contract is...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,557,240 units of the prescription drug Advair HFA 230-21 MCG Inhaler 12GM. The contract has a completion date of February 6, 2024 and a potential value of $6,901.94. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside program. This...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $5,393.88 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, for the provision of Advair HFA 115-21 mcg inhalers. This delivery order, with a period of performance through April 2, 2024, is issued under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 that enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical...
The Defense Logistics Agency has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract worth $2,082.64 to supply Advair HFA 115-21 mcg inhalers. The contract has a performance period through January 30, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is a for-profit organization based in Conshohocken, Pennsylvania. This delivery order contract is part of a larger...
  • SPE2DX15D3015
    Indefinite Delivery Contract
  • SPE2DX15D3015-SPE2DX24F0FA2
    Delivery Order

The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Advair HFA 230-21 mcg inhaler 12 gm. The $2,760.48 contract has a completion date of February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract with the Defense Logistics Agency valued at up to $999,999,999.00 through December 31, 2025 to deliver a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. This contract award does not have a set-aside designation.

Generated 5/8/24, 9:55 AM